Carlsbad, CA, United States of America

Ru Zhou

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 5.9

ph-index = 4

Forward Citations = 59(Granted Patents)


Location History:

  • San Diego, CA (US) (2010 - 2012)
  • Carlsbad, CA (US) (2000 - 2023)

Company Filing History:


Years Active: 2000-2023

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovative Journey of Ru Zhou

Introduction

Ru Zhou, an accomplished inventor based in Carlsbad, California, has made significant contributions to the field of pharmaceuticals with her innovative research and development. With a remarkable portfolio of 16 patents, she has become a key figure in the realm of drug discovery and development.

Latest Patents

Among her latest patents, Ru Zhou has developed azalactam compounds as HPK1 inhibitors. This invention relates to compounds described by a general Formula I. These compounds hold great potential in the treatment of various diseases, showcasing her ability to push the boundaries of current pharmaceutical therapies.

Career Highlights

Ru Zhou's career has been marked by her association with renowned companies such as Agouron Pharmaceuticals, Inc. and Pfizer Corporation. These affiliations have allowed her to leverage her research in high-impact environments, contributing to important advancements in the pharmaceutical industry.

Collaboration

Throughout her career, Ru has collaborated with notable colleagues, including Peter Scott Dragovich and Thomas Jay Prins. These partnerships have enhanced her innovation capacity, fostering an environment of shared knowledge and expertise in her research initiatives.

Conclusion

In summary, Ru Zhou stands out as a prolific inventor whose work has the potential to reshape the landscape of pharmaceutical treatments. Through her continuous dedication to research and collaboration, she exemplifies the spirit of innovation that drives progress in today's healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…